About VigiEye

VigiEye is a daily news service on EU and US pharmaceutical regulation: approvals, pharmacovigilance and PRAC safety signals, quality and GMP, clinical-trials rules, market access, guidelines and the PDUFA calendar.

VigiEye is written for regulatory affairs, pharmacovigilance, quality, clinical and market-access professionals. Every story starts from a primary record (a regulator's website, an official journal, or a company filing with the US Securities and Exchange Commission), and every story links back to that record so readers can check it.

Who publishes VigiEye

VigiEye is published by PQRA, the regulatory, quality and pharmacovigilance consultancy of Dimitrios Gkikas, based in Marousi, Athens, Greece. PQRA has worked in pharmaceutical regulatory affairs, quality and pharmacovigilance for clients in Greece and Cyprus, and that experience decides what the site covers and how it explains it.

Our sister site CompePharma covers the business of pharma: deals, financing, launches and earnings.

How the site is funded

The news is free to read. The site is funded by advertising (Google AdSense), by its paid products, and by clearly labelled house advertisements for PQRA's consulting services. Advertisers have no influence on what we cover.

How stories are written

See our editorial policy for our sources, our use of AI tools and how to ask for a correction.